Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Ribitol - ML Bio Solutions

Next Previous
X
Search
Drug Profile

Ribitol - ML Bio Solutions

Alternative Names: Adonitol; BBP 418

Latest Information Update: 07 Oct 2024

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Atrium Health
  • Developer ML Bio Solutions
  • Class Small molecules; Sugar alcohols
  • Mechanism of Action Glycosylation stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Limb girdle muscular dystrophies
  • New Molecular Entity Yes

Highest Development Phases

  • Phase III Limb girdle muscular dystrophies

Most Recent Events

  • 30 Sep 2024 BridgeBio Pharma completes enrollment in phase-III trial in Limb girdle muscular dystrophies (In adolescents, In adults) in Germany, USA, Australia, Denmark, Italy, Netherlands, Norway and the United Kingdom (PO) (NCT05775848)
  • 01 Aug 2024 BridgeBio completes Type C meeting with the US FDA for Limb-girdle muscular dystrophies
  • 18 Jun 2024 The US FDA has grants Rare Pediatric Disease Designation (RPDD) for BBP 418 in the treatment of Limb-girdle Muscular Dystrophy Type 2I/R9

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top